These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 327371)

  • 1. Histocompatibility matching in poor prognosis combined procedure keratoplasty.
    Bennett TO; Peyman GA
    Ophthalmic Surg; 1977 Apr; 8(2):42-8. PubMed ID: 327371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility matching in poor-prognosis penetrating keratoplasty.
    Bennett TO; Peyman GA; Tissot R; Cohen C
    Acta Ophthalmol (Copenh); 1975 Jun; 53(3):403-17. PubMed ID: 1101625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matching of the minor histocompatibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation.
    Böhringer D; Spierings E; Enczmann J; Böhringer S; Sundmacher R; Goulmy E; Reinhard T
    Transplantation; 2006 Oct; 82(8):1037-41. PubMed ID: 17060851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of corneal graft survival in infants and children with peters anomaly.
    Yang LL; Lambert SR; Lynn MJ; Stulting RD
    Ophthalmology; 1999 Apr; 106(4):833-48. PubMed ID: 10201611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative importance of risk factors used to define high-risk keratoplasty.
    Hill JC
    Ger J Ophthalmol; 1996 Jan; 5(1):36-41. PubMed ID: 8646178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of corneal graft rejection by passive cell transfer.
    Khodadoust AA; Silverstein AM
    Invest Ophthalmol; 1976 Feb; 15(2):89-95. PubMed ID: 1357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for failure of simultaneous penetrating keratoplasty and cataract extraction.
    Bersudsky V; Rehany U; Rumelt S
    J Cataract Refract Surg; 2004 Sep; 30(9):1940-7. PubMed ID: 15342059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal oedema after cataract surgery: predisposing factors and corneal graft outcome.
    Claesson M; Armitage WJ; Stenevi U
    Acta Ophthalmol; 2009 Mar; 87(2):154-9. PubMed ID: 18537927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term graft survival after penetrating keratoplasty.
    Thompson RW; Price MO; Bowers PJ; Price FW
    Ophthalmology; 2003 Jul; 110(7):1396-402. PubMed ID: 12867398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicted long-term outcome of corneal transplantation.
    Borderie VM; Boëlle PY; Touzeau O; Allouch C; Boutboul S; Laroche L
    Ophthalmology; 2009 Dec; 116(12):2354-60. PubMed ID: 19815285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Australian Corneal Graft Registry. 1990 to 1992 report.
    Aust N Z J Ophthalmol; 1993 May; 21(2 Suppl):1-48. PubMed ID: 8333942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of immunological incompatibility and the methods of controlling it in keratoplasty].
    Lazarenko LF; Gundorova RA; Iushko NA; Bordiugova GG; Arkhipova LT
    Vestn Oftalmol; 1976; (6):57-61. PubMed ID: 798395
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic endothelial cell loss of the graft after penetrating keratoplasty: influence of endothelial cell migration from graft to host].
    Reinhard T; Böhringer D; Hüschen D; Sundmacher R
    Klin Monbl Augenheilkd; 2002 Jun; 219(6):410-6. PubMed ID: 12136435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty.
    Böhringer D; Reinhard T; Duquesnoy RJ; Böhringer S; Enczmann J; Lange P; Claas F; Sundmacher R
    Transplantation; 2004 Feb; 77(3):417-21. PubMed ID: 14966417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation antigens and keratoplasty.
    Stark WJ
    Dev Ophthalmol; 1981; 5():33-40. PubMed ID: 6177566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of corneal transplantation: I--graft clarity.
    Cherry PM; Pashby RC; Tadros ML; Wolf A; Chipman ML; Basu PK; Dixon WS; Hunter WS; Thompson GA
    Ann Ophthalmol; 1979 Mar; 11(3):461-9. PubMed ID: 378085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B and -DR match reduces the allograft reaction after keratoplasty.
    Hoffmann F; Tregel M; Noske W; Bünte S
    Ger J Ophthalmol; 1994 Mar; 3(2):100-4. PubMed ID: 8193569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.